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With the advent of levodopa (L-dopa) and the recognition of its striking effect on Parkinson’s disease
(PD), virtually all surgical procedures for PD ceased from the mid 1960s. However, there has been a
resurgence of pallidotomy and other stereotactic procedures in the last two decades as physicians realized
that most PD patients eventually face medical failure after long-term treatment with L-dopa. Nine PD
patients, three men and six women, with an average age of 62 years and disease duration of 13 years
underwent unilateral globus pallidus internus (GPi) pallidotomy contralateral to the side with marked
akinetic symptoms and drug-induced dyskinesia. All patients were evaluated using the Unified Parkinson’s
disease Rating Scale (UPDRS) after drug withdrawal and while taking their optimal medical regimen,
preoperatively and 6, 12, and 24 months after surgery. There was significant improvement in activities
of daily living and motor subscores as well as total UPDRS score in the “off” state at the 2-year follow-
up, which mainly resulted from improvement in contralateral bradykinesia and rigidity. Significant
improvements in contralateral akinetic symptoms and drug-induced dyskinesia were also observed in
the “on” state and were sustained for at least 2 years. Ipsilateral and axial symptoms were not altered
by unilateral GPi pallidotomy. The complications of surgery were generally well tolerated. One patient
had a small postoperative asymptomatic hemorrhage identified by routine follow-up magnetic resonance
imaging. Another two patients developed temporary sexual disinhibition and auditory hallucination,
respectively, which resolved spontaneously 2 weeks after surgery. The effect of pallidotomy for alleviation
of akinetic parkinsonism is modest but significant, and continues to be effective for at least 2 years. Further
analytical studies, especially the correlation of clinical effects and lesion locations, are important not only
to provide direct feedback for surgeons to examine the technical accuracy and but also to facilitate
understanding of the pathophysiology of PD.
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Pallidotomy originated from incidental ligation of the
anterior choroidal artery [1] and was replaced by thalam-
otomy due to its suboptimal effect on tremor [2]. Its use
finally ground to a complete standstill after the introduction
of levodopa (L-dopa), but pallidotomy has attracted renewed
interest for the treatment of Parkinson’s disease (PD) in the
last two decades since Laitinen et al reported successful
experience with Leksell’s posteroventral globus pallidus
internus (GPi) lesioning [3].
Several developments are responsible for the renewed
interest in surgical treatment of PD. First, although a strik-
ing response is usually observed after initial L-dopa treat-
ment, with progression of the illness and chronic medical
treatment, the response to L-dopa is less predictable and
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less sustained, leading to wide spontaneous and dose-
related fluctuations in motor function (the on-off phe-
nomenon). Over time, the “off” period will increase and
patients usually develop drug-induced involuntary move-
ment (dyskinesia) during the “on” period. In addition,
anti-parkinsonian drugs can bring psychiatric or cognitive
complications. Second, advances in stereotactic techniques
as well as neuroimaging and neurophysiologic monitoring
have made functional neurosurgical procedures more
accurate and safer. Third, the pathophysiology and the
neuronal substrates responsible for the symptoms charac-
terizing PD, namely bradykinesia, rigidity, and tremor,
are now better understood. Studies in a nonhuman pri-
mate model of PD induced by methyl-phenyl-tetrahydro-
pyridine (MPTP) provide a strong rationale for pallidotomy
and other surgical strategies.
PD patients with tremor-dominant parkinsonism at
Kaohsiung Medical University Hospital undergo stereo-
tactic ventral intermediate (Vim) thalamotomy, while most
patients, who present with akinetic-rigid symptoms as well
as drug-induced dyskinesia with or without tremor, are
treated with pallidotomy. Nine PD patients undergoing
unilateral pallidotomy with complete 2-year follow-up were
included in this study. We present our surgical techniques
in detail as well as the clinical outcomes and operative
complications.
PATIENTS AND METHODS
Patient selection
In cooperation with a movement disorder neurologist,
we began performing stereotactic neurosurgery at our insti-
tute in 1999. Patients with idiopathic PD in later stages who
have failed medical therapy and have reached a level of
impairment in activities of daily living (ADL) are referred
to our surgical team. However, end-stage patients who
are bed-bound or have significant cognitive or psychiatric
problems unlikely to benefit from surgery are not offered
surgical treatment. We initially chose patients with
asymmetric appendicular parkinsonian symptoms. Nine
PD patients who underwent unilateral GPi pallidotomy
from July 1999 to July 2001 and had complete follow-up
data were included in this study. For the sake of congruity,
patients who underwent unilateral pallidotomy and there-
after contralateral thalamotomy or pallidotomy were not
included. Patients included in the study had significant
parkinsonian symptoms with Hoehn and Yahr staging of
3.8 ± 0.4 during the “off” period and were experiencing
dyskinesia during the “on” period despite appropriate
pharmacotherapy.
Clinical evaluation
Assessments were conducted by a neurologist before surgery
(baseline) and at 6, 12, and 24 months after pallidotomy.
Based on the Core Assessment Program for Intracerebral
Transplantation definition, all patients were scored after a
12-hour drug-free period to assess the worst “off” state and
1–2 hours after their usual morning medications to evaluate
the best “on” state.
Clinical evaluation was carried out by means of the
Unified Parkinson’s Disease Rating Scale (UPDRS). Modified
Hoehn and Yahr staging was assessed and minimal mental
status evaluation (MMSE) was also used to evaluate the
cognitive effect of the surgery [4]. Subcomponents of the
motor subset in UPDRS were used to study the effects of
unilateral pallidotomy on ipsilateral and contralateral
bradykinesia, rigidity, and tremor. All items of the motor
subset in which laterality was not specified were grouped
under the general denomination of axial symptoms. Doses
of anti-parkinsonian medications were also evaluated
before and after surgery; postoperative anti-parkinsonian
medications were generally maintained at the preoperative
levels, although some patients reduced their dose due to
improved condition in the early postoperative period.
Target determination
Medications were withheld overnight before surgery to en-
sure the patient was in a relative “off” state to minimize
involuntary movement during imaging and to assess the
clinical effects of pallidotomy during surgery. After the Lek-
sell stereotactic frame was applied to the patient’s head, two
magnetic resonance imaging (MRI) sets were obtained.
Volumetric gradient echo T1-weighted images (T1WIs),
covering the whole brain in 2 mm axial slices, were obtained
for indirect targeting. Axial T2WIs were obtained using 2
mm non-overlapping slices through the basal ganglia for
direct visualization of the target. Target coordinates were
determined with the assistance of Leksell Surgiplan (Elek-
ta, Atlanta, GA, USA), in which images can be fused and
reformatted to parallel the anterior commissure–posterior
commissure (AC–PC) plane and displayed in different
orthogonal views. The initial target was chosen to be 3 mm
anterior to the mid-commissural point, 5 mm below the
AC–PC line, and 19–22 mm lateral to the midline (more
lateral for patients with a larger third ventricle) according
to atlas-based coordinates on T1WI. Adjustments were
then made depending on direct visualization of the GPi in
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relation to the internal capsule on the axial plane and to the
optic tract on the coronal plane according to T2WIs, which
were fused with volumetric images. In a minority of cases
where the outer border of the GPi could not be well
delineated, a resident digitized atlas helped to check the
target position in various planes and the placement of the
target was adjusted if necessary.
Surgical procedure
Once the target coordinates were obtained, the patient was
transferred to the operating theater. Under local anesthesia,
a burr hole was placed 3 cm lateral to the midline at the
coronal suture contralateral to the side with the most
disabling symptoms. Macrostimulation was performed
using an electrode introduced to a point 6 mm above the
planned target and then moved deeper by 2 mm intervals.
Low-frequency stimulation was used to obtain the motor
threshold and high-frequency stimulation was used to as-
sess proximity to the optic tract. The target was adjusted if
necessary to put it posteriorly and ventrally enough but not
to cause injury to the internal capsule and optic tract. High-
frequency macrostimulation was also used to test the
amelioration of PD symptoms by checking the rigidity of
the joint and asking patients to perform finger or foot
tapping and rapid pronation and supination of the fore-
arm. Speech function was also evaluated from volume,
articulation, and fluency. Facial contraction or finger
movement under low current amplitude meant that the
target was too close to the internal capsule and vice versa.
Phosphene observed by patients provided important
information on the relationship between the target and
the optic tract. In four of nine patients, we were not able to
elicit this phenomenon and the placement of the target
was guided by motor responses and relief of symptoms.
Adjustments of the final target were determined after
integrating information about alleviation of symptoms
and undesired effects. The number of trajectories used to
define the best target point ranged between two and four.
Once the target was determined, a test lesion was made
using radiofrequency thermocoagulation (60°C, 60 sec-
onds) with a thermocoupled stereotactic electrode. If
no undesired effect was detectable after repeating the
motor, visual and speech tests, final lesions were created
using 80°C for 80 seconds at the target point and repeated
2 and 4 mm above (Figure 1).
Statistical analysis
Statistical analyses were carried out using SPSS version
10.1 (SPSS Inc, Chicago, IL, USA). Pre- and postoperative
scores were analyzed by means of pair-wise comparisons
using the Wilcoxon signed rank test for each variable. To
evaluate the possible changes over time, all variables were
studied using analysis of variance (ANOVA) with repeated
measures, where the repeated measure was the interval
between clinical assessments. All statistical analyses were
performed with two-tailed probability; an alpha level of p
less than 0.05 was used to determine significance.
RESULTS
Three males and six females with a mean age of 62 years
(range, 46–82 years) and disease duration of 13 years (range,
9–17 years) were included in the study. Unilateral pos-
teroventral pallidotomy was performed on the left side
in three patients and on the right side in six. Baseline Hoehn
and Yahr staging in the “off” state was 3.8 ± 0.4 (range, 3–5)
(Table 1). The MMSE score was within the normal range.
Other clinical baseline characteristics including UPDRS
scores and subscores in “off” and “on” states are depicted
in Tables 1 and 2.
Figure 1. Unilateral lesion on the left posteroventral globus pallidus
internus (black arrow).
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“Off“ state evaluation at 2-year follow-up
In the “off“ state, ADL and motor scores improved sig-
nificantly at 2-year follow-up by 21% and 18%, respec-
tively (Table 1). Changes in UPDRS scores are illus-
trated in Figure 2. The improvement in motor score was
mostly due to improvement in bradykinesia (46%) and
rigidity (52%) on the side contralateral to pallidotomy.
Although the subscore for contralateral tremor also
improved by 40%, this was not statistically significant.
Ipsilateral motor symptoms seemed to have progressed
by the 2-year follow-up (not statistically significant),
except for rigidity. The Hoehn and Yahr staging, UPDRS
subset I (mentation, behavior, and mood), and axial
symptoms did not change significantly.
“On“ state evaluation at 2-year follow-up
During the “on“ period, there was sustained improve-
ment in contralateral bradykinesia and rigidity, which we
attributed to better compliance with medications due to
elimination of drug-induced dyskinesia (Table 2). Ipsilater-
al motor symptoms did not improve and even worsened
with time, which was especially evident for tremor. Drug-
Table 1. Mean “off” scores at baseline and at 6 and 12 months and 2 years after surgery
Scale Score Baseline 6 months 12 months 2 years p*
Hoehn and Yahr 1–5 3.8 ±  0.4 2.8 ±  0.7 3.2 ±  0.7 3.3 ±  0.5 0.102
UPDRS total 0–176 58.7 ±  13.6 38.2 ±  11.1 44.2 ±  12.9 46.3 ±  12.7 0.036
UPRDS-1 0–16 3.6 ±  1.5 3.2 ±  1.0 4.7 ±  2.1 4.8 ±  2.3 0.157
UPDRS-2 0–52 17.4 ±  6.6 9.6 ±  5.1 11.0 ±  7.0 11.0 ±  6.1 0.015
UPDRS-3 0–108 37.7 ±  10.1 25.4 ±  8.5 28.6 ±  7.3 30.6 ±  7.8 0.028
Axial symptoms 0–36 12.7 ±  4.8 11.0 ±  6.7 11.3 ±  4.0 11.6 ±  4.5 0.550
Ipsilateral
  Bradykinesia 0–16 5.8 ±  2.9 4.3 ±  1.7 5.8 ±  2.5 6.1 ±  1.8 0.776
  Rigidity 0–8 2.7 ±  1.2 1.4 ±  1.1 1.7 ±  1.5 2.0 ±  1.8 0.236
  Tremor 0–12 1.7 ±  1.3 1.6 ±  1.3 2.3 ±  2.1 2.6 ±  2.6 0.190
Contralateral
  Bradykinesia 0–16 8.7 ±  3.3 4.3 ±  2.2 4.0 ±  2.1 4.7 ±  2.1 0.012
  Rigidity 0–8 3.2 ±  1.4 1.3 ±  1.0 1.3 ±  1.1 1.6 ±  1.2 0.014
  Tremor 0–12 3.0 ±  2.2 1.3 ±  1.0 2.0 ±  2.4 1.9 ±  2.1 0.087
*Between baseline and 2-year assessment, using Wilcoxon signed rank test. Data are presented as mean scores ±  standard deviation; lower
scores indicate better function. UPDRS = Unified Parkinson’s Disease Rating Scale.
Table 2. Mean “on” scores at baseline and at 6 and 12 months and 2 years after surgery
Scale Score Baseline 6 months 12 months 2 years p*
Hoehn and Yahr 1–5 3.1 ±  0.5 2.6 ±  0.5 2.8 ±  0.4 2.9 ±  0.5 0.257
UPDRS-total 0–176 45.0 ±  9.5 30.4 ±  7.9 35.2 ±  12.5 41.1 ±  13.7 0.373
UPDRS-1 0–16 2.9 ±  0.9 2.6 ±  0.7 4.3 ±  2.4 4.4 ±  2.4 0.048
UPDRS-2 0–52 14.7 ±  5.2 8.7 ±  4.8 9.3 ±  5.4 11.6 ±  5.3 0.205
UPDRS-3 0–108 27.4 ±  6.6 19.2 ±  5.4 21.6 ±  7.3 25.1 ±  9.0 0.261
Axial symptoms 0–36 7.6 ±  3.1 6.4 ±  3.7 7.1 ±  3.7 7.8 ±  4.9 1.0
Dyskinesia 0–12 4.2 ±  1.6 1.1 ±  1.1 1.3 ±  1.7 1.8 ±  1.9 0.015
Ipsilateral
  Bradykinesia 0–16 4.3 ±  2.3 3.0 ±  1.2 3.8 ±  2.3 4.8 ±  2.1 0.340
  Rigidity 0–8 2.0 ±  0.9 1.1 ±  0.9 1.2 ±  1.2 1.3 ±  1.5 0.230
  Tremor 0–12 1.4 ±  1.1 1.2 ±  1.1 1.7 ±  1.0 2.3 ±  1.0 0.038
Contralateral
  Bradykinesia 0–16 6.7 ±  2.7 4.1 ±  2.0 3.6 ±  1.9 4.3 ±  2.3 0.011
  Rigidity 0–8 2.4 ±  0.5 1.1 ±  0.8 1.2 ±  1.1 1.3 ±  1.0 0.023
  Tremor 0–12 3.0 ±  2.1 2.2 ±  1.6 3.0 ±  2.2 3.2 ±  2.4 0.414
*Between baseline and 2-year assessment, using Wilcoxon signed rank test. Data are presented as mean scores ±  standard deviation; lower
scores indicate better function. UPDRS = Unified Parkinson’s Disease Rating Scale.
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induced dyskinesia improved significantly by 57%.
ADL and motor scores as well as axial symptoms did not
change significantly in the “on” state. There was signifi-
cant worsening of the subset I score.
Comparison between 6- and 12-month and 2-year
follow-up
In the “off“ state, subscores for contralateral bradykinesia
and rigidity as well as ADL and motor symptoms improved
significantly at the first follow-up and this was sustained
until the last follow-up (Figure 3). There was no signifi-
cant effect on axial symptoms after the first evaluation.
Contralateral tremor was improved at 6 months and
ipsilateral rigidity was improved at 6 and 12 months of
follow-up, but the effects waned thereafter (Figure 4).
In the “on“ state, contralateral bradykinesia and rigidity
improved initially, which persisted for 2 years (Figure 5).
Significant improvements in contralateral tremor and
ipsilateral bradykinesia were observed at the first follow-
up but lost between 6 and 12 months. The improvement in
motor score was observed at the first two follow-ups but be-
came insignificant due to worsened ipsilateral symptoms.
Improvement in ADL at the first and second follow-ups
also waned at the last follow-up. Axial symptoms did not
change over time. Of note, there was significant deteriora-
tion in the subscore for mentation, behavior, and mood at
the 12-month follow-up. Dyskinesia remained markedly
improved for at least 2 years.
Complications
No patients presented with motor weakness or visual field
defects. One patient had a small, asymptomatic subclinical
hemorrhage at the lesion site, which was found during
routine postoperative follow-up MRI. One patient presented
with sexual disinhibition and another with auditory
hallucination following pallidotomy. The symptoms
resolved spontaneously within 2 weeks after surgery.
Follow-up MRI showed optimal target location without
Figure 2. Changes in Unified Parkinson’s Disease Rating Scale (UPDRS)
scores among nine patients undergoing unilateral pallidotomy. 1 =
baseline; 2 = 6 months; 3 = 12 months; 4 = 2 years.
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Figure 3. “Off” period scores for contralateral bradykinesia, rigidity,
and tremor. *p < 0.05 baseline versus different follow-up evaluations.
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Figure 4. “Off” period scores for ipsilateral bradykinesia, rigidity, and
tremor. *p < 0.05 baseline versus different follow-up evaluations.
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other abnormality. Four patients experienced obvious
weight gain; the mechanism was unclear, although neuro-
psychologic factors and elimination of dyskinesia have
been reported to be related [5]. All patients showed signi-
ficant improvement in symptoms accompanied by bet-
ter ADL and appetites according to family observations.
Due to the small number of cases and great variation in
educational level, extensive neuropsychologic assessment
could not be done properly. According to evaluation with
MMSE and UPDRS subset I, patient’s mentality seemed to
deteriorate. We were unable to draw a conclusion about
whether the deterioration was a result of the natural course
of PD or pallidotomy.
DISCUSSION
Disturbance in the basal ganglia, particularly hyperactivity
of the GPi and subthalamic nucleus (STN) resulting from
dopamine deficiency, produces excessive inhibitory outflow
to the thalamus which, in turn, prevents the downstream
regulation of the motor cortex leading to the disordered and
impoverished movement in PD. The overactivity of the GPi
and STN in the pathophysiology of parkinsonism has been
identified via a nonhuman primate model and is supported
by the observations that lesions or delivery of electric current
to these targets ameliorate parkinsonian symptoms in MPTP-
treated monkeys as well as PD patients. Using functional
imaging, reversal of diminished activation in the supple-
mentary motor area and premotor area has been reported
in PD patients after GPi pallidotomy [6].
Considerable data are now accumulating to support the
efficacy of posteroventral GPi pallidotomy in later-stage
PD [7–9]. In general, most studies agree that pallidotomy
has a pronounced effect on L-dopa-induced dyskinesia and
cardinal motor dysfunction in “off” state parkinsonism
contralateral to the side of surgery. Our results are com-
patible with other groups’ reports showing long-term
significant improvement in contralateral bradykinesia
and rigidity [7–10]. The elimination of L-dopa-induced dys-
kinesia enabled us to use anti-parkinsonian medications
more liberally and increased patients’ drug compliance,
which in turn contributed to improve “on” state bradykine-
sia and rigidity. Alleviation of contralateral tremor was not
significant, which we attributed to the small number of
cases and the bias due to selection of akinesia-dominant
PD patients with fewer tremor symptoms (6 patients with
contralateral tremor scores ≤ 3 during the “off” period).
Global improvement was obvious according to “off” state
total UPDRS score as well as ADL and motor subscores,
and persisted for at least 2 years. Axial symptoms, which
can be improved by unilateral surgery [10], were not obvi-
ously improved in our patients. The surgical benefits on
the ipsilateral side, apart from some short-term effects
on rigidity, were neither marked nor sustained, which is
consistent with other reports in the literature [8].
Unlike the STN, whose boundary is difficult to delineate
using modern imaging techniques, targeting the most
medial, ventral, and posterior part of the GPi can be achieved
using MRI. Traditionally, the target of pallidotomy has
been defined based on the stereotactic atlas. The atlas
method, defining targets in reference to the AC–PC line, is
more consistent for those lying not far from the midline
such as the STN or Vim of the thalamus. The GPi, which is
the farthest target from the third ventricle, presents with
widest variation between each individual and even from
side to side of the same brain [11]. Changing the MRI
parameters enhances the boundary between the GPi and
the posteromedial internal capsule and underneath the
optic tract. Using planning software with reconstructed
images at different planes helps to determine the lesion
location and correct the errors caused by improper place-
ment of the frame. A built-in deformable atlas also facili-
tates delineation of the border of the GPi in unusual cases
where the GPi cannot be seen properly by adjusting
Figure 5. “On” period scores for dyskinesia, contralateral bradykinesia,
rigidity, and tremor. *p < 0.05 baseline versus different follow-up
evaluations.
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the MRI acquisition parameters.
The role of microelectrode recordings in the localization
of the STN is generally accepted, but its role in pallidotomy
is still under debate [12,13]. The aim of microelectrode
recordings is to provide physiologic data about the selected
target as well as its surroundings, thereby optimizing
creation of the lesion. Anatomic-functional dissociation
of the target, brain shift during surgery, and imaging in-
accuracies are the basic considerations calling for physio-
logic corroboration by microelectrode recordings. How-
ever, high-quality images provided by new MRI tech-
niques and physiologic data from intraoperative macro-
stimulation using the patient’s response to stimulation
have solved most of the problems. Many groups have
reported comparable results with pallidotomy without
the aid of microelectrode recordings [9,12]. Even though
more information can be derived from microelectrode
recordings, it is not without complications. A higher
incidence of hemorrhage has been reported and cost-
effectiveness is another consideration due to the require-
ment for expensive instruments, trained personnel, and
tedious evaluation with prolonged operation time.
As knowledge about the pathophysiology of basal
ganglia and the clinical outcome data of various surgical
procedures become available, preference for different sur-
gical targets and a more rational treatment approach should
emerge. Bilateral pallidotomy is supposed to benefit PD
patients with bilateral and axial disability. Scott et al have
reported a 53% improvement in UPDRS score in patients
undergoing bilateral pallidotomy compared to 27%
improvement after unilateral surgery [14]. However, the
higher incidence of complications such as speech dys-
function and cognitive deterioration should be kept in
mind when selecting bilateral ablative procedures [15].
Recently, interest has been shifted to deep brain stimula-
tion (DBS). The advantage of DBS is its non-destructive
and adaptable nature. Although the mechanism of DBS is
not well understood, functional images have shown that
GPi stimulation, like pallidotomy, reduces excessive inhi-
bition of the thalamocortical circuit. However, wide-scale
use is not a practical option so far considering the limited
health care resources and lack of long-term results. Lesion-
ing at the STN to influence the entire output of the basal
ganglia (GPi and substantial nigra par reticulata) could be
a promising alternative, but the procedure necessitates
a much more delicate approach by experienced hands be-
cause of the high incidence of worrisome hemiballism.
In conclusion, posteroventral GPi pallidotomy has
substantial and long-term effects on contralateral
parkinsonism during “off” and “on” periods, which
improves PD patients’ motor activity. The effect on
dyskinesia is also marked and sustained. There was no
measurable benefit for axial and ipsilateral symptoms in
our series. Further evaluations, especially of the location
and size of the ablative lesion and its correlation with
clinical outcome, would not only give surgeons feedback,
enabling refinement of the surgical techniques, but also
provide important pathophysiologic insights into PD.
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